מחלקת הקורונה בבית החולים שיבא, תל השומר
The COVID ward at Sheba Medical Center, Israel's largest hospital
Photo: Tal Shahar
An elderly woman receives a booster shot of her vaccination against the coronavirus disease (COVID-19) at an assisted living facility, in Netanya, Israel January 19, 2021

Third Pfizer dose 86% effective in over 60s, Israeli HMO says

A trial conducted by Maccabi shows that only 37 people out of 149,144 who had received their third jab, contracted coronavirus, compared to 1,064 positive cases among those who had received only two doses of the vaccine

Reuters |
Published: 08.18.21, 17:06
A third dose of Pfizer/BioNTech's COVID-19 vaccine was found to be 86% effective in people aged over 60, an Israeli healthcare provider said on Wednesday, citing initial results from a study of thousands of members.
  • Follow Ynetnews on Facebook and Twitter

  • Israeli HMO Maccabi, which covers around a quarter of the country's 9.3 million population, compared results from 149,144 people aged over 60 who received their third dose at least a week ago against those from 675,630 more who had received only two doses, between January and February.
    4 צפייה בגלריה
    An elderly woman receives a booster shot of her vaccination against the coronavirus disease (COVID-19) at an assisted living facility, in Netanya, Israel January 19, 2021
    An elderly woman receives a booster shot of her vaccination against the coronavirus disease (COVID-19) at an assisted living facility, in Netanya, Israel January 19, 2021
    An elderly woman receives a booster shot of her vaccination against the coronavirus disease (COVID-19) at an assisted living facility, in Netanya, Israel January 19, 2021
    (Photo: Reuters )
    Some 37 people tested positive for coronavirus after their third jab, compared with 1,064 positive cases among those who had received only two doses, Maccabi said in a statement. The comparison groups had similar demographic profiles, it added.
    Maccabi did not provide any information on the severity of the 37 positive cases, or whether they had any underlying conditions.
    The Health Maintenance Organization (HMO) did not immediately respond to a request for comment.
    4 צפייה בגלריה
    מחלקת הקורונה בבית החולים שיבא, תל השומר
    מחלקת הקורונה בבית החולים שיבא, תל השומר
    The COVID ward at Sheba Medical Center, Israel's largest hospital
    (Photo: Tal Shahar)
    Pfizer has said that its vaccine's efficacy drops over time, and that a third dose showed significantly higher neutralizing antibodies against the initial SARS-CoV-2 virus as well as against the Beta and highly infectious Delta variants.
    Israel began administering third Pfizer doses last month to confront a surge in local infections driven by the Delta variant. Some 1.1 million eligible Israelis - people over 50, healthcare workers, and others - have received their third dose.
    4 צפייה בגלריה
    נפתלי בנט מלווה את אמו להתחסן בפעם השלישית
    נפתלי בנט מלווה את אמו להתחסן בפעם השלישית
    Prime Minister Naftali Bennett accompanies his mother as she recives the third jab
    (Photo: Elad Gershgoren)
    The United States and several European countries are expected to begin offering boosters to the elderly and people with weak immune systems, and some are considering whether to make a third dose available more widely.
    Nonetheless, Israeli health officials worry that cases will continue to mount given that another 1.1 million Israelis - around 11% of the population - remain unvaccinated. Severe cases have also continued to climb, mostly among the unvaccinated.
    4 צפייה בגלריה
    מבצע חיסונים של מד"א ועיריית תל אביב בכיכר דיזנגוף
    מבצע חיסונים של מד"א ועיריית תל אביב בכיכר דיזנגוף
    People waiting in line to receive the third jab in Tel Aviv
    (Photo: Moti Kimchi)
    Health ministry data released on Wednesday, based on data per 100,000 people, showed 172 serious cases among unvaccinated people over 60, compared with 21 serious cases among vaccinated individuals in the same age group.
    Dr. Anat Ekka Zohar of Maccabi said that the third dose "has again proved its effectiveness," and had "demonstrated protection (against) the Delta variant".

    Talkbacks for this article 0